Nalaganje...

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of drugs that have been extensively investigated for the treatment of hyperglycemia in type 2 diabetes mellitus (T2DM). These drugs reduce hyperglycemia by blocking renal glucose reabsorption, thereby promoting increased renal gluco...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cardiol Ther
Glavni avtor: Kalra, Sanjay
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5125111/
https://ncbi.nlm.nih.gov/pubmed/27539303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40119-016-0069-z
Oznake: Označite
Brez oznak, prvi označite!